| Dec 11, 2025 |
Dec 15, 2025 |
Vera Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+5,882
|
0.11%
|
✗
|
$250K |
| Oct 9, 2025 |
Oct 14, 2025 |
Zenas BioPharma, Inc.
|
Director |
Buy |
95.0
|
+117,255
|
6.79%
|
✗
|
$2.3M |
| Aug 7, 2025 |
Aug 11, 2025 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
90.0
|
+1,702
|
6.90%
|
✗
|
$200.8K |
| Jun 23, 2025 |
Jun 25, 2025 |
Vera Therapeutics, Inc.
|
Director |
Buy |
88.8
|
+250,000
|
2.38%
|
✗
|
$5.3M |
| Sep 27, 2024 |
Sep 27, 2024 |
BioAge Labs, Inc.
|
Director |
Buy |
100.0
|
+400,000
|
30.52%
|
✗
|
$7.2M |
| Sep 16, 2024 |
Sep 16, 2024 |
Zenas BioPharma, Inc.
|
Director |
Buy |
100.0
|
+440,000
|
131.53%
|
✗
|
$7.5M |
| Nov 7, 2023 |
Nov 9, 2023 |
Lexeo Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+454,545
|
21.52%
|
✗
|
$5M |
| Aug 11, 2023 |
Aug 15, 2023 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
90.0
|
+1,834
|
9.60%
|
✗
|
$171.5K |
| Feb 6, 2023 |
Feb 8, 2023 |
Vera Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+1,714,285
|
100.00%
|
✗
|
$12M |
| Nov 22, 2022 |
Nov 25, 2022 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
17.5
|
-6,974
|
-26.73%
|
✗
|
$1M |
| Aug 5, 2022 |
Aug 9, 2022 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
90.0
|
+1,472
|
5.98%
|
✗
|
$165.9K |
| Feb 10, 2022 |
Apr 5, 2022 |
Vera Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+333,333
|
10.76%
|
✗
|
$5M |
| Jul 19, 2021 |
Jul 20, 2021 |
RAPID MICRO BIOSYSTEMS, INC.
|
10% Owner |
Buy |
100.0
|
+150,000
|
100.00%
|
✗
|
$3M |
| May 18, 2021 |
May 18, 2021 |
Vera Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+909,090
|
41.56%
|
✗
|
$10M |
| May 11, 2021 |
May 11, 2021 |
Tourmaline Bio, Inc.
|
10% Owner |
Buy |
95.0
|
+235,000
|
7.87%
|
✗
|
$4M |
| Nov 12, 2020 |
Nov 13, 2020 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
5.0
|
-9,929
|
-32.77%
|
✓
|
$1.5M |
| Jul 10, 2020 |
Jul 14, 2020 |
89bio, Inc.
|
10% Owner |
Buy |
92.5
|
+109,090
|
4.38%
|
✗
|
$3M |
| Nov 11, 2019 |
Nov 13, 2019 |
89bio, Inc.
|
10% Owner |
Buy |
100.0
|
+575,000
|
100.00%
|
✗
|
$9.2M |
| Aug 8, 2019 |
Aug 12, 2019 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
90.0
|
+1,194
|
7.25%
|
✗
|
$98.5K |
| Sep 6, 2018 |
Sep 7, 2018 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
5.0
|
-10,130
|
-38.08%
|
✓
|
$1.7M |
| Aug 9, 2018 |
Aug 13, 2018 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
72.5
|
+130
|
0.80%
|
✗
|
$239.1K |
| Dec 11, 2017 |
Dec 13, 2017 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
5.0
|
-9,000
|
-35.52%
|
✓
|
$1.3M |
| Dec 8, 2017 |
Dec 12, 2017 |
COLLEGIUM PHARMACEUTICAL, INC
|
10% Owner |
Sell |
15.0
|
-1,000,000
|
-30.10%
|
✗
|
$17.3M |
| Nov 17, 2017 |
Nov 21, 2017 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
53.8
|
-352
|
-0.16%
|
✓
|
$46.9K |
| Aug 25, 2017 |
Aug 28, 2017 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
50.0
|
-351
|
-0.16%
|
✓
|
$52.1K |
| Aug 10, 2017 |
Aug 14, 2017 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
65.0
|
+703
|
0.32%
|
✗
|
$94.2K |
| Jul 25, 2017 |
Jul 27, 2017 |
KALA BIO, Inc.
|
10% Owner |
Buy |
100.0
|
+215,000
|
10.46%
|
✗
|
$3.2M |
| Mar 16, 2017 |
Mar 20, 2017 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
17.5
|
-269,955
|
-4.23%
|
✗
|
$2.7M |
| Mar 13, 2017 |
Mar 15, 2017 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
16.3
|
-600,000
|
-7.59%
|
✗
|
$6.1M |
| Mar 8, 2017 |
Mar 10, 2017 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
16.3
|
-750,000
|
-8.66%
|
✗
|
$7.3M |
| Feb 23, 2017 |
Feb 27, 2017 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
15.0
|
-2,500,000
|
-22.40%
|
✗
|
$22M |
| Dec 2, 2016 |
Dec 6, 2016 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
48.8
|
-677
|
-0.30%
|
✓
|
$68.9K |
| Nov 22, 2016 |
Nov 25, 2016 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
37.5
|
-36,941
|
-0.26%
|
✗
|
$345.2K |
| Nov 17, 2016 |
Nov 21, 2016 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
16.3
|
-544,100
|
-3.74%
|
✗
|
$5.2M |
| Nov 15, 2016 |
Nov 17, 2016 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
17.5
|
-174,847
|
-1.19%
|
✗
|
$1.7M |
| Aug 15, 2016 |
Aug 17, 2016 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
40.0
|
-633
|
-0.28%
|
✗
|
$86.4K |
| Feb 10, 2016 |
Feb 12, 2016 |
Jazz Pharmaceuticals plc
|
Director |
Sell |
32.5
|
-10,000
|
-4.32%
|
✓
|
$1.2M |
| May 12, 2015 |
May 14, 2015 |
COLLEGIUM PHARMACEUTICAL, INC
|
10% Owner |
Buy |
95.0
|
+200,000
|
6.41%
|
✗
|
$2.4M |
| Mar 20, 2015 |
Mar 24, 2015 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
16.3
|
-1,089,745
|
-2.67%
|
✗
|
$6.3M |
| Mar 19, 2015 |
Mar 23, 2015 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
15.0
|
-500,000
|
-34.86%
|
✗
|
$55.8M |
| Nov 17, 2014 |
Nov 19, 2014 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
2.5
|
-487,130
|
-25.35%
|
✓
|
$16M |
| Oct 9, 2014 |
Oct 14, 2014 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
57.5
|
-943
|
-0.05%
|
✓
|
$28.3K |
| Oct 7, 2014 |
Oct 9, 2014 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
30.0
|
-11,927
|
-0.62%
|
✗
|
$358.3K |
| May 1, 2014 |
May 5, 2014 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
40.0
|
-250,000
|
-1.93%
|
✓
|
$1M |
| Apr 1, 2014 |
Apr 3, 2014 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
40.0
|
-250,000
|
-1.90%
|
✓
|
$1.1M |
| Mar 5, 2014 |
Mar 7, 2014 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
40.0
|
-250,000
|
-1.86%
|
✓
|
$1M |
| Jul 1, 2013 |
Jul 1, 2013 |
Esperion Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+216,676
|
12.61%
|
✗
|
$3M |